Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail
-

Epoprostenol for injection, 1.5 mg vial
Company: GeneraMedix, Inc.
NDA: 022260
Approval Date: 6/27/2008

Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.

 

Date created: November 6, 2008

Back to Top    Drugs@FDA

 

Note: Documents in PDF format require the Adobe Acrobat Reader®.

-
-